FDA Drug Recalls

Recalls / Class II

Class IID-1066-2017

Product

Glycopyrrolate Injection Solution, 2 mL 0.4 mg/2 mL (0.2 mg/mL) Single-Dose Syringe, Rx Only, Cantrell Drug Company 7321 Cantrell Rd Little Rock, AR 72207 877-666-5222; NDC 52533-028-16

Affected lot / code info
Lot #: 9781, BUD: 7/26/2017; 9784, BUD: 7/27/2017; 9822, BUD: 8/2/2017; 9852, BUD: 8/5/2017; 10061, BUD: 9/7/2017; 10105, BUD: 9/13/2017; 10150, BUD: 9/17/2017; 10178, BUD: 9/22/2017; 10185, BUD: 9/23/2017; 10501, BUD: 11/8/2017

Why it was recalled

Lack of Sterility Assurance.

Recalling firm

Firm
Cantrell Drug Company
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
7321 Cantrell Rd, N/A, Little Rock, Arkansas 72207-4144

Distribution

Quantity
21080 syringes
Distribution pattern
Nationwide within the US

Timeline

Recall initiated
2017-07-14
FDA classified
2017-08-09
Posted by FDA
2017-08-16
Terminated
2020-09-16
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1066-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.